List of bibliographic references
Number of relevant bibliographic references: 18.
| Ident. | Authors (with country if any) | Title |
|---|
| 000020 (2009) |
Robert Hart [États-Unis] ; Lesly Pearce [États-Unis] ; Bernard Ravina [États-Unis] ; Toby Yaltho [États-Unis] ; John Marler [États-Unis] | Neuroprotection trials in Parkinson's disease: Systematic review |
| 000033 (2008) |
A Schapira [Royaume-Uni] | Progress in neuroprotection in Parkinson’s disease |
| 000098 (2009) |
A Schapira [Royaume-Uni] ; Y Agid [France] ; P Barone [Italie] ; P Jenner [Royaume-Uni] ; M Lemke [Allemagne] ; W Poewe [Autriche] ; O Rascol [France] ; H Reichmann [Allemagne] ; E Tolosa [Espagne] | Perspectives on recent advances in the understanding and treatment of Parkinson’s disease |
| 000119 (2008) |
C Olanow [États-Unis] ; Robert Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000153 (2002) |
Nicole Abramova [États-Unis] ; David Cassarino [États-Unis] ; Shaharyar Khan [États-Unis] ; Terry Painter [États-Unis] ; James Bennett [États-Unis] | Inhibition by R(+) or S(–) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH‐SY5Y neuroblastoma |
| 000187 (2011) |
Peter Jenner [Royaume-Uni] ; J Langston [États-Unis] | Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline |
| 000259 (2009) |
Na Kim [Corée du Sud] ; Byung Choi [Corée du Sud] ; Xian Huang [Corée du Sud] ; Brian Snyder [Canada] ; Shefqat Bukhari [Canada] ; Tae Kong [Corée du Sud] ; Hyeonseon Park [Corée du Sud] ; Hyung Park [Corée du Sud] ; So Park [Corée du Sud] ; Yoon Ha [Corée du Sud] | Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model |
| 000304 (2007) |
Anthony Schapira [Royaume-Uni] | Future directions in the treatment of Parkinson's disease |
| 000320 (2010) |
Chao Li [États-Unis, République populaire de Chine] ; S Biswas [États-Unis] ; Xingang Li [République populaire de Chine] ; A Dutta [États-Unis] ; Weidong Le [États-Unis] | Novel D3 dopamine receptor‐preferring agonist D‐264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine and lactacystin |
| 000368 (2009) |
Robert Hauser [États-Unis] ; Mark Lew [États-Unis] ; Howard Hurtig [États-Unis] ; William Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Cheryl Fitzer [Israël] | Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease |
| 000512 (2002) |
A Schapira | Dopamine agonists and neuroprotection in Parkinson's disease |
| 000763 (2005) |
Pedro Barroso [Espagne] ; Ignacio Cruz [Espagne] ; María Aymerich [Espagne] ; Manuel Rodríguez [Espagne] ; Domingo Afonso [Espagne] ; José Lanciego [Espagne] ; Tomás González [Espagne] | Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells |
| 000765 (2005) |
B Jakobsen [Danemark] ; J Gramsbergen [Danemark] ; A M [Danemark] ; C Rosenblad [Danemark] ; J Zimmer [Danemark] | Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP+ toxicity by GDNF |
| 000879 (2008) |
Anthony Schapira [Royaume-Uni] | The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease |
| 000981 (2008) |
Maryka Quik [États-Unis] ; Kathryn O [États-Unis] ; Caroline Tanner [États-Unis] | Nicotine and Parkinson's disease: Implications for therapy |
| 000B53 (2011) |
Robert Altman [Canada] ; Anthony Lang [Canada] ; Ronald Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
| 000E91 (2009) |
Hitoshi Nakayama [Japon] ; Jing Zhao [Japon] ; Amany Ei [Japon] ; Minoru Isosaki [Japon] ; Hiroyasu Satoh [Japon] ; Yoji Kyotani [Japon] ; Masanori Yoshizumi [Japon] | Neuroprotective effects of pramipexole against tunicamycin‐induced cell death in PC12 cells |
| 001578 (2004) |
G. Gille [Allemagne] ; S Hung [Allemagne] ; H. Reichmann [Autriche] ; W Rausch [Autriche] | Oxidative Stress to Dopaminergic Neurons as Models of Parkinson's Disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i -k "neuroprotection"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i \
-Sk "neuroprotection" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= Istex
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= neuroprotection
}}
| This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024 |  |
